Frontiers in Cardiovascular Science Archived Talks

2014

Cardioprotection: A Tale of Two Mechanisms

Joseph Hill, MD, PhD
The James T. Willerson, MD, Distinguished Chair in Cardiovascular Diseases

Frank M. Ryburn Jr.
Chair in Heart Research

December 9, 2014

The Signal and the Noise: Predicting Atrial Fibrillation and Stroke Using Big Data Approaches -- Implications for Mobile Health and Wearable Tech

Mintu Turakhia, MD, MAS
Assistant Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy at the Palo Alto Veterans Affairs Health Care System

November 25, 2014

The Changing Epidemiology of Atrial Fibrillation and Stroke: Is it a Vascular Disease

Bernard J. Gersh, J MB, ChB, Dphil, FACC

November 11, 2014

Cardiac iPSCs for Disease Modeling and Drug Discovery

Joseph Wu, MD, PhD
Professor of Medicine (Cardiology) and Radiology, Stanford University
Director of the Stanford Cardiovascular Institute

November 4, 2014

Ultrasound Molecular Imaging in Cardiovascular Medicine and Drug Development

Jonathan R. Lindner, MD
M. Lowell Edwards Professor of Cardiology Knight Cardiovascular Institute, Oregon Health & Science University

October 21, 2014

Cardiovascular Research: Challenges and Opportunities Locally and Globally

Kenneth Mahaffey, MD
Vice Chair of Clinical Research, Department of Medicine; Professor of Medicine (Cardiovascular Medicine) Stanford

October 7, 2014

Experiences in Drug Discovery

Roy Vagelos, MD
Chairman of the Board, Regeneron Pharmaceuticals
Retired Chairman and Chief Executive Officer of Merck & Co.

September 23, 2014

A Case for Microvascular Pathology in Chronic Right Ventricular Failure

Norbert Voelkel, MD
Professor (Affiliate), School of Pharmacy, Virginia Commonwealth University

September 16, 2014

2017 | 2016 | 2015 | 2014